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Summary
Although maternal deaths are among the most tragic events related to pregnancy, they are 
uncommon in the United States and therefore, inadequate indicators of a woman’s pregnancy-
related health. Maternal morbidity has become a more useful measure for surveillance and 
research. Traditional attempts to monitor maternal morbidity have used hospital discharge data, 
which include data only on complications that resulted in hospitalization, thus underestimating the 
frequency and scope of complications. To obtain a more accurate assessment of morbidity, we 
applied a validated computerized algorithm to identify pregnancies and pregnancy-related 
complications in a defined population of women enrolled in a health maintenance organization in 
the southeastern United States. We examined the most common morbidities by pregnancy 
outcome and maternal characteristics.
We identified 37,741 pregnancies; in half (50.7%), at least 1 complication occurred. The 5 most 
common were urinary tract infections, anemia, mental health conditions, pelvic and perineal 
complications, and obstetric infection. We observed that in pregnancies among non-Hispanic 
White women, low socioeconomic status (SES) had a modest effect on the adjusted odds of 
preexisting medical conditions [adjusted odd ratio (AOR) 1.33, 95% confidence interval (CI) 1.21, 
1.47] or having any morbidity [AOR 1.27, 95% CI 1.16, 1.38]. Low SES had little effect on 
complications among non-Hispanic Black women. Compared with pregnancies among non-
Hispanic White women, those among non-Hispanic Black women had more complications and 
occurred more often in women with low SES; however, SES did not affect their likelihood of 
morbidity. Even for non-Hispanic White women, the effect of SES was small, suggesting that the 
influence of SES on the risk of morbidity may be ameliorated by comprehensive health insurance 
coverage.
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Introduction
Maternal deaths, among the most tragic events related to pregnancy, are uncommon in the 
United States1–4 and thus are difficult to use as an indicator of a woman’s health and health 
care during pregnancy, delivery, and the postpartum period. Maternal morbidity, defined as 
conditions resulting from or exacerbated by pregnancy that adversely affect the woman’s 
health, has not been the focus of measurement, monitoring, or research as no systematic 
population-based collection of data on pregnancy-related complications exists. Nonetheless, 
as our knowledge of maternal morbidity has evolved, understanding the development of 
morbidity affords a more comprehensive picture of women’s health during pregnancy. 
While severe complications pose greater risks to a woman’s well-being, mild and moderate 
complications are more common and some of these can have a substantial impact on the 
economic, psychological, and physical health of the woman and her family. Given the 
approximately 6 million pregnancies each year in the United States, even small advances in 
our knowledge of maternal morbidity can improve the pregnancy experience of many 
women and inform research and clinical efforts to identify complications early and prevent 
progression along the morbidity continuum.1,3,5–8
When attempting to estimate the types and prevalence of maternal morbidity, researchers 
have considerable obstacles to overcome. In traditional attempts to monitor maternal 
morbidity, hospital discharge databases have been used, but these contain data only on 
complications that resulted in hospitalization during the antepartum and intrapartum 
periods.9,10 Prevalences derived from these data sources underestimate the actual frequency 
of maternal complications because they do not include morbidity treated in outpatient 
settings or occurring during the postpartum period. Many of the most common 
complications of pregnancy, such as anemia, urinary tract infections, and mental health 
conditions, usually do not require hospitalization and, therefore, are not ascertained 
accurately in estimates based on hospitalization data.
We previously reported the extent of maternal morbidity in an integrated healthcare delivery 
system in the Pacific Northwest.11,12 For the current study, we adapted the validated 
computerized algorithms developed in the previous project to identify pregnancies and 
associated complications in a defined and more diverse population of women enrolled in a 
health maintenance organization (HMO) in the southeastern United States. We present 
prevalence estimates of the most common morbidities by pregnancy outcome and maternal 
characteristics, including an index of neighborhood socioeconomic status (SES).
Methods
This study was conducted using 2000–2006 electronic data from Kaiser Permanente Georgia 
(KPGA), a nonprofit group- and network-model HMO that provides comprehensive medical 
insurance coverage and services to approximately 275,000 members in the Atlanta, GA 
metropolitan area. We adapted a validated computerized algorithm that links indicators and 
dates of pregnancies and pregnancy outcomes to create pregnancy “episodes”. Then we 
searched these pregnancy episodes for ICD-9-CM (International Classification of Diseases, 
9th Revision, Clinical Modification) codes indicating 36 predetermined, clinically-relevant 
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morbidity groups. A detailed description of the methods used to develop and validate this 
algorithm11 and the rates of maternal morbidity found using the morbidity algorithm in the 
Kaiser Permanente Northwest (KPNW) population12 are published elsewhere.
Pregnancy outcomes included were live birth, stillbirth, ectopic gestation, spontaneous 
abortion, and therapeutic abortion. The study population comprised females aged 11–54 
years who were insured by KPGA from the beginning of the pregnancy episode through 8 
weeks after delivery. The analytic unit was the pregnancy episode. If a woman had more 
than 1 pregnancy episode during the study period, data from all episodes were included.
Pregnancy episodes and outcomes were initially identified by using the original algorithm to 
search individual-level KPGA outpatient, inpatient, emergency services, laboratory, and 
imaging computerized administrative databases for ICD-9-CM diagnosis and procedure 
codes, CPT-4 and NDC codes, or other indicators of pregnancy.11 An electronic file of all 
the pregnancies identified by the algorithm was provided to the Vital Statistics Department 
of the Georgia Division of Public Health. The Vital Statistics Department linked the KPGA 
live birth and stillbirth data with their Georgia birth and fetal death certificates using the 
woman’s Social Security Number, name, date of birth, and date of delivery.
For live births and stillbirths, the majority of data on gestational age, race, ethnicity, and 
parity (number of viable previous pregnancies) came from Georgia birth certificates and the 
remaining data from KPGA files; for other pregnancy outcomes, all data came from KPGA 
files. Maternal age and neighborhood SES index quartile were obtained or computed from 
KPGA files. After identifying pregnancies, we used the morbidity algorithm to ascertain the 
corresponding morbidities.12
Race and ethnicity data from birth certificate files are self-reported and grouped according to 
the Office of Management and Budget (OMB)-defined race and ethnicity categories. We 
examined pregnancy-related complications by race and ethnicity to improve our 
understanding of potential differences in these health outcomes by race category, with the 
ultimate goal of reducing these disparities. Because of the well-established differences in 
obstetric outcomes between non-Hispanic Black and White women, we were particularly 
interested in examining these relationships more closely.
The SES index variable was computed by creating a factor score using principal components 
analysis of 7 variables from the U.S. Census SF3 file (http://www.census.gov/census2000/
sumfile3.html) and the KPGA enrollee’s geocoded address. Addresses were geocoded by 
mapping to the exact latitude and longitude and to county, zip code, and 2000 U.S. Census 
tract or block group using MapMarker® Plus (MapInfo Corporation, Troy, NY). The 7 
Census variables were percentage of households: (1) with income below poverty level; (2) 
receiving public assistance; (3) with annual income <$30,000; (4) with working-age adult 
males not in the labor force; (5) with adults aged ≥25 years who had a high school education 
or less; and log of: (1) median household income; and (2) median value of single family 
homes.13,14 In descriptive analyses, the SES index was categorized into quartiles (low, mid-
low, mid-high, and high). For multivariable modeling, a 2-level variable was computed (low 
and mid-low categories were combined into ‘low’, mid-high and high were combined into 
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‘high’). The SES index has been validated for KPGA by comparison with self-reported 
education attainment and household income from 3 surveys of KPGA adult enrollees.
Using the 36 maternal morbidity groups, we computed morbidity rates overall and for each 
pregnancy outcome. Women could have had more than 1 complication during a pregnancy 
episode. Among pregnancies that resulted in a live birth, we examined differences in 
morbidity by 4 categories of race/ethnicity (non-Hispanic Black, hereafter referred to as 
Black; non-Hispanic White, hereafter referred to as White; Asian/Pacific Islander (API); and 
Hispanic). To look more closely at the relationships among race/ethnicity, SES index, and 
morbidity, we conducted a sub-analysis using logistic regression and constructed separate 
multivariable models for Black women and White women. We assessed the odds of any 
morbidity as well as 3 categories of morbidity (preexisting medical conditions, obstetric 
conditions, and mental health conditions) associated with the 2-level SES index variable, 
stratified by race/ethnicity and adjusted for age and parity. Logistic regression analyses were 
conducted using SAS software (version 9.1; SAS Institute Inc., Cary, NC). Because mothers 
with >1 pregnancy are included in our data set, we performed analyses using generalized 
estimating equations (GEE) to correct for correlation within subjects. This study was 
approved by the Institutional Review Boards of the Centers for Disease Control and 
Prevention, Kaiser Permanente Northwest, and Kaiser Permanente Georgia.
Results
We identified 37,741 pregnancies among 28,916 women enrolled in KPGA between January 
1, 2000 and December 31, 2006. Evidence in the KPGA databases indicated that 25,342 of 
these pregnancies resulted in live birth or stillbirth outcomes. Georgia birth and fetal death 
certificates were linked to 24,020 live births and stillbirths (match rate = 94.8%). Most of 
the 37,741 pregnancies were among women who were between ages 20 and 39, parous, and 
had a live birth; 42.9% were Black, 33.2% White, 8.0% API, and 4.4% Hispanic (Table 1). 
Race/ethnicity was obtained mostly from birth certificate files. Consequently, this 
information was missing for 10.9% of pregnancies, the majority of which (90.6%) resulted 
in a spontaneous or therapeutic abortion; no birth certificate would have been generated for 
these pregnancy outcomes. The proportion of White and API pregnancies in each SES 
category increased as the SES index increased. The pattern was the opposite for Black 
women: over half of the pregnancies among Black women were in the low and mid-low SES 
index quartile.
The prevalence of each of the 36 morbidity groups and their corresponding ICD-9-CM 
codes are presented in Table 2. We examined the 10 most common morbidities by 
pregnancy outcome (Table 3). At least 1 complication occurred in 50.7% of pregnancies, 
and >1 complication occurred during many pregnancies. The prevalence of morbidity varied 
by pregnancy outcome: 60.6% among live births, 52.4% among stillbirths, 31.0% among 
spontaneous abortions, and 26.5% among therapeutic abortions.
Overall, the 5 most common complications were urinary tract infections, nonhereditary 
nonhemolytic anemia, mental health conditions, pelvic and perineal complications, and 
obstetric infection. Each of the 10 most common morbidities had a prevalence of 5% or 
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greater in at least 1 pregnancy outcome group. Urinary tract infections, mental health 
conditions, and chronic hypertension occurred frequently during pregnancies with all 
outcomes; however, these conditions predominated among pregnancies resulting in a live 
birth.
Restricting the analysis to pregnancies ending in a live birth, we examined the 10 most 
common complications by maternal race/ethnicity (Table 4). At least 1 complication was 
recorded during 64.2% of pregnancies among Black women, 59.2% among White women, 
53.8% among Hispanic women, and 56.0% among API women. Most of the individual 
complications occurred more frequently among Black women; the exceptions were mental 
health conditions, pregnancy-induced hypertension, and pelvic and perineal complications. 
Nearly 20% of pregnancies among Black women were complicated by anemia. Rates of 
urinary tract infections were common in pregnancies across all race and ethnic groups 
(10.2–15.9%) as were pelvic and perineal complications (6.5–11.3%) and obstetric infection 
(4.4–8.1%). Pregnancies in all race and ethnic groups were frequently complicated by 
gestational diabetes (abnormal glucose tolerance). The prevalence ranged from 4.6% among 
Black women to 8.6% among API women.
Given the differences we observed in the neighborhood SES index for pregnancies among 
Black and White women (Table 1), as well as the variation in the prevalence of 
complications between these 2 groups (Table 4), we conducted multivariable modeling to 
examine the relationship between neighborhood SES and morbidity overall and stratified by 
race/ethnicity. Crude analyses indicated that the odds ratio (OR) of any morbidity occurring 
in pregnancies of Black women compared with those of White women was 1.23 [95% 
confidence interval (CI) 1.17, 1.30]. For women whose SES index was low compared with 
high, the crude OR was 1.24 [95% CI 1.18, 1.31] (data not shown). Odds ratios and 95% CI 
for morbidities associated with SES index and adjusted for age and parity are shown 
separately for Black and White women in Table 5. During pregnancies among White 
women, low SES index had a modest effect on the odds of preexisting medical conditions 
complicating the pregnancy [OR 1.33, 95% CI 1.21, 1.47] and on the odds of having any 
morbidity [OR1.27, 95% CI 1.16, 1.38]. Low SES had little effect on complications among 
Black women.
Discussion
Although the prevalence and type of morbidity varied by pregnancy outcome, 51% of 
pregnancies in our study were affected by at least 1 complication during the prenatal, labor 
and delivery, or postpartum period. The prevalence ranged from 54% among Hispanic 
women to 64% among Black women. Among pregnancies ending in a live birth, urinary 
tract infection (14.8%) and anemia (13.4%) were the most common complications. While 
these conditions are usually mild, they affect large numbers of women and increase the use 
of health care services.
As in other health indicators, racial/ethnic differences in many obstetric outcomes are well 
known. The risk of maternal mortality is 4 times higher for Black women compared with 
White women.15–17 Black women have about twice the risk of preterm delivery18 and 
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stillbirth,19 compared with White women. Black infants have 2.4 times the mortality rate of 
White infants.20 In a review of racial/ethnic disparities in pregnancy outcomes, obstetric 
care, and selected maternal morbidities, Bryant and colleagues2 found that, compared with 
White women, Black women had a higher risk of hypertensive disorders of pregnancy, 
prepregnancy hypertension, and prepregnancy diabetes. They also found that Black women 
with asthma, genitourinary infections, and periodontal disease fared worse during pregnancy 
than White women with these conditions.
We observed that compared with all other race/ethnic groups, a greater proportion of 
pregnancies of Black women were in the lowest neighborhood SES group and were 
associated were at least 1 complication. However, in multivariable analyses, SES had 
essentially no effect on the complication risk for Black women. Others have found a similar 
lack of effect of SES on infant outcomes for Black women. In a study comparing very low 
birthweight rates between Black and White women in Georgia, Berg and colleagues21 found 
that although Black women were more socioeconomically disadvantaged than White 
women, low SES did not increase their risk of having a very low birthweight infant.
Little has been published on the joint relationships among SES, race/ethnicity, and maternal 
morbidity in an insured population of women. Moreover, studies of maternal morbidity 
often have marked differences in methodology, populations, and conditions studied, making 
comparisons difficult. In our study, all women had health insurance coverage for obstetric 
care and thus, theoretically at least, had similar financial access to similar quality 
antepartum, intrapartum, and postpartum care. Although the rate of complications during 
pregnancies among Black women, compared with those among White women was higher 
(64% compared with 59%), and low SES was more prevalent among Black women (64% 
compared with 34%), SES did not affect the likelihood of morbidity in pregnancies among 
Black women as it did for White women. The SES variable in our study has been validated 
using a KPGA member survey; further, it represents socioeconomic features of the 
neighborhood in which the woman resides, which has been shown to be a robust metric.22 
However, our findings suggest that this variable may function differently or have a different 
significance for Black and White women. Despite our study population’s universal health 
insurance coverage, there may have been differences in access and proximity to health care 
facilities, and in health-related behaviors. Other unidentified or unmeasured factors also may 
have played a role in our results. Finally, even for White women, the effect of SES is small, 
suggesting that the degree to which SES influences the risk of morbidity may be ameliorated 
by comprehensive health insurance coverage. Research is warranted to explore these 
relationships further. Monitoring to determine whether these patterns persist may be useful 
as health insurance coverage expands under health care reform.
Our study was limited by our reliance on ICD-9-CM codes for diagnoses of pregnancy-
related complications. When used to identify specific conditions, these codes vary in their 
accuracy. The effect of coding errors appears to be greater, however, when used to identify 
rare or ill-defined conditions or severe morbidity.1,6,24 In validation studies, several 
investigators have found that morbidity codes have acceptable sensitivity and high 
specificity.23,24 Moreover, we had the ability to detect ICD-9-CM codes at multiple 
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encounters throughout the pregnancy, not just at the hospitalization for delivery, thus 
enhancing sensitivity.
To the extent that findings from studies of maternal morbidity can be compared, our results 
are similar to patterns observed by others, but ours are of broader scope. Data from the 
National Hospital Discharge Survey (NHDS)25 and the Nationwide Inpatient Sample (NIS) 
from the Healthcare Cost and Utilization Project (HCUP)27 are the primary national data 
sources for monitoring pregnancy-related complications. However, analyses using NHDS, 
NIS, or HCUP likely underestimate morbidity as they include only complications that result 
in hospitalization, or that occur and are coded during delivery hospitalizations; conditions 
treated in outpatient settings and those that occur in the postpartum period are not captured. 
Moreover, hospitalization databases contain events of hospitalizations and they are not 
longitudinally linked to a person. Finally, race data from nationally representative hospital 
discharge databases are incomplete because many hospitals do not collect or provide race 
data.9,25–27 We obtained race from both KPGA and birth certificate data; notably, in 2005, 
race of mother was reported on U.S. birth certificates for 99.3% of all births.28 Because of 
the racial, ethnic, and socioeconomic diversity of the KPGA population, we were able to 
examine how these factors affect maternal morbidity. Our study was further strengthened by 
having individual-level data from every inpatient and outpatient encounter within the KPGA 
health system, enabling us to estimate morbidity rates per woman.
Several studies have examined rates of severe maternal morbidity, intrapartum morbidity, 
and selected complications during the delivery hospitalization.1,3,5,6,10,26,29–31 While each 
of these studies suggests a useful framework for measuring important aspects of maternal 
morbidity, none provides a comprehensive system. We present an approach for estimating 
overall and specific pregnancy-related complication rates in a defined population. With 
minor adjustments to our original algorithm, we were able to replicate our earlier study in a 
different managed care setting. Our data source allowed us to capture a broad spectrum of 
antepartum, intrapartum, and postpartum morbidity in a diverse population of women 
experiencing all pregnancy outcomes.
Complications of pregnancy range from mild to life-threatening. They are common, and can 
have a significant impact on women, their families, and the health care system. Many 
complications are likely to recur in subsequent pregnancies. Several researchers have called 
for the development of a national surveillance system so that complications can be better 
ascertained, monitored, and studied.5,32–35 However, the lack of clear definitions and 
consistent methods hinders attempts to conduct national surveillance. A practical alternative 
may be to establish a system of monitoring selected priority morbidities, and factors 
associated with them, in defined populations, such as multiple managed care 
organizations36–38. Such a system could be built on routinely collected data, as described in 
our study, or modified to collect data prospectively. These data could be used to estimate 
incidence and prevalence; review cases and explore factors associated with progression of 
the morbidity; examine the organization and management of obstetric care; and implement 
guidelines and monitor practice changes aimed at prevention of adverse pregnancy-related 
events.
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Table 2
Prevalence of the 36 morbidity groups and their corresponding ICD-9-CM codes, all pregnancy outcomesa
Morbidity group
Frequency
N (%) ICD-9-CM codes
Obstetric complications
 Hemorrhage
  Placenta previa without hemorrhage 317 (0.84) 641.0
  Antepartum hemorrhage 1387 (3.67) 641.1–641.3, 641.8–641.9, 762.0–762.1
  Postpartum hemorrhage 874 (2.32) 666.0–666.2, 639.1
 Obstetric trauma
  Pelvic and perineal trauma 2134 (5.65) 654.3, 664.2–664.3, 664.5, 665.2–665.5, 665.7–665.9, 674.1–674.3, 674.8–674.9 
(if live birth or still birth: 639.2)
  Uterine rupture 28 (0.07) 665.0, 665.1
 Hypertensive disorders
 Chronic hypertension 1668 (4.42) 401–405, 642.0, 642.1, 642.2, 760.0
 Pregnancy-induced hypertension 1638 (4.34) 642.3, 642.4, 642.5, 642.6, 642.7, 642.9
 Infection
  Obstetric infection 1724 (4.57) 038.0–038.9, 041.0–041.9, 567.0–567.9, 614.3, 615.0–615.9, 639.0, 658.4, 659.3, 
670.Xc, 672.X, 760.2, 762.7
  Urinary tract infection 4519 (12.0) 590.0–590.9, 595.0–595.9, 599.0, 646.5, 646.6
  Pneumonia 201 (0.53) 480.0–480.9, 481.X, 482.0–482.9, 483.X, 485.X, 486.X
  Appendicitis 36 (0.10) 540.0–540.9, 541.X, 542.X
  Infections not classified elsewhere 263 (0.70) 052.0–052.9, 070.0–070.9, 487.0–487.8
 Other
  Abnormal glucose tolerance 1327 (3.52) 648.8
  Excess vomiting 1515 (4.01) 643.0–643.9
  Thrombophlebitis and embolism 93 (0.25) 415.1, 451.1, 671.3–671.5, 673.0–673.8
  Cerebrovascular disorders 52 (0.14) 430.X, 431.X, 432.0–432.9, 434.0–434.0, 436.X, 437.6, 674.0
  Disseminated intravascular coagulation 112 (0.30) 286.6–286.9, 666.3
  Breast disorders 616 (1.63) 611.0, 611.2, 675.0–675.9
  Complications of anesthesia 125 (0.33) 349.0, 668.X
  Complications of spontaneous abortion 348 (0.92) 634.X, 637.X, 639.X
  Complications of therapeutic abortion 59 (0.16) 635.X, 637.X, 639.X
Preexisting medical conditions
 Nonhereditary, nonhemolytic anemia 3614 (9.58) 280.0–280.9, 281.0–281.9, 285.9, 648.2
 Hereditary hemolytic anemia 341 (0.90) 282.X
 Clotting disorders 189 (0.50) 286.4, 287.3, 287.5
 Tuberculosis 22 (0.06) 010.0–010.9, 011.0–011.9, 012.0–012.8, 013.0–013.9, 014.0–014.9, 015.0–015.9, 
016.0–016.9, 017.0–017.9, 018.0–018.9, 647.3
 HIV 37 (0.10) 042, 043, 044
 Diabetes in pregnancy 1124 (2.98) 250.0–250.9, 648.0
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Morbidity group
Frequency
N (%) ICD-9-CM codes
 Thyroid disorders 638 (1.69) 242.0–242.9, 648.1
 Gall bladder disease 202 (0.54) 574.0–574.9, 575.0–575.9
 Renal disease 283 (0.75) 580.0–580.9, 581.0–581.9, 582.0–582.9, 583.0–583.9, 585.X, 586.X, 592.0–
592.9, 646.2, 760.1
 Liver disorders 52 (0.14) 571.0–571.9, 646.7
 Asthma 1035 (2.74) 493.X
 Neurologic conditions 38 (0.10) 351.0, 646.4
 Cardiovascular condition 684 (1.81) 393.X, 394.0–394.9, 395.0–395.9, 396.0–396.9, 397.0–397.9, 398.0–398.9, 
410.0–410.9, 413.0–413.9, 414.0, 424.0–424.9, 648.5–648.6, 441.0–441.9, 
442.0–442.9
 Other chronic disease 247 (0.65) 135.X, 555.X, 556.X, 710.X, 714.X, 760.3, 760.8
Mental health conditions 2349 (6.22) 295.0–295.9, 296.0–296.9, 297.0–297.9, 298.0–298.9, 300.0–300.9, 309.0, 309.1, 
311.X, 648.4, E950–958
a
“X” in the place of the fourth digit means that each fourth and fifth digit of the code is included or that the code has no digits to the right of the 
decimal point.
Paediatr Perinat Epidemiol. Author manuscript; available in PMC 2015 August 18.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Bruce et al. Page 15
Ta
bl
e 
3
Pr
ev
al
en
ce
 (N
 [%
]) 
of 
the
 10
 m
os
t c
om
mo
n p
reg
na
nc
y-r
ela
ted
 co
mp
lic
ati
on
s b
y p
reg
na
nc
y o
utc
om
ea
Li
ve
 b
ir
th
St
ill
bi
rt
h
SA
B 
b
TA
B 
c
A
ll 
ou
tc
om
es
A
ny
 c
om
pl
ic
at
io
n
15
03
1 
(60
.6)
29
1 
(52
.4)
14
35
 (3
1.0
)
19
37
 (2
6.5
)
19
11
6 
(50
.7)
U
rin
ar
y 
tra
ct
 in
fe
ct
io
n
36
66
 (1
4.8
)
87
 (1
5.7
)
29
6 
(6.
4)
41
7 
(5.
7)
45
19
 (1
2.0
)
A
ne
m
ia
33
18
 (1
3.4
)
48
 (8
.6)
13
1 
(2.
8)
74
 (1
.0)
36
14
 (9
.6)
M
en
ta
l h
ea
lth
 c
on
di
tio
ns
16
86
 (6
.8)
51
 (9
.2)
23
8 
(5.
1)
35
0 
(4.
8)
23
49
 (6
.2)
Pe
lv
ic
 a
nd
 p
er
in
ea
l c
om
pl
ic
at
io
ns
21
16
 (8
.5)
6 
(1.
1)
≤5
0
21
34
 (5
.7)
O
bs
te
tri
c 
in
fe
ct
io
n
15
58
 (6
.3)
56
 (1
0.1
)
69
 (1
.5)
25
 (0
.3)
17
24
 (4
.6)
Ch
ro
ni
c 
hy
pe
rte
ns
io
n
13
30
 (5
.4)
45
 (8
.1)
15
1 
(3.
3)
11
6 
(1.
6)
16
68
 (4
.4)
Pr
eg
na
nc
y-
in
du
ce
d 
hy
pe
rte
ns
io
n
16
15
 (6
.5)
12
 (2
.2)
≤5
≤5
16
38
 (4
.3)
Ex
ce
ss
 v
om
iti
ng
13
66
 (5
.5)
20
 (3
.6)
43
 (0
.9)
83
 (1
.1)
15
15
 (4
.0)
A
nt
ep
ar
tu
m
 h
em
or
rh
ag
e
11
11
 (4
.5)
38
 (6
.8)
19
3 
(4.
2)
21
 (0
.3)
13
85
 (3
.7)
A
bn
or
m
al
 g
lu
co
se
 to
le
ra
nc
e
13
05
 (5
.3)
6 
(1.
1)
12
 (0
.2)
≤5
13
27
 (3
.5)
a
In
cl
ud
es
 O
th
er
/M
iss
in
g 
ra
ce
/e
th
ni
ci
ty
 a
nd
 a
ll 
pr
eg
na
nc
y 
ou
tc
om
es
.
b S
A
B 
= 
Sp
on
ta
ne
ou
s a
bo
rti
on
c T
A
B 
= 
Th
er
ap
eu
tic
 (i
nd
uc
ed
) a
bo
rti
on
Paediatr Perinat Epidemiol. Author manuscript; available in PMC 2015 August 18.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Bruce et al. Page 16
Table 4
Prevalence of the 10 most common pregnancy-related complications among those with known race/ethnicity; 
live births only
Live Births
N (%)
Complications Black
N=10,137
White
N=10,462
Hispanic
N=1,373
APIa
N=2,495
Any 6507 (64.2) 6198 (59.2) 738 (53.8) 1397 (56.0)
Urinary tract infection 1611 (15.9) 1555 (14.9) 197 (14.3) 255 (10.2)
Anemia 1944 (19.2) 915 (8.7) 151 (11.0) 264 (10.6)
Pelvic and perineal complications 796 (7.9) 912 (8.7) 89 (6.5) 281 (11.3)
Mental health conditions 523 (5.2) 1002 (9.6) 64 (4.7) 69 (2.8)
Pregnancy induced hypertension 650 (6.4) 791 (7.6) 73 (5.30 82 (3.3)
Obstetric infection 817 (8.1) 510 (4.9) 61 (4.4) 149 (6.0)
Excess vomiting 666 (6.6) 478 (4.6) 61 (4.4) 138 (5.5)
Chronic preexisting hypertension 828 (8.2) 414 (4.0) 30 (2.2) 48 (1.9)
Abnormal glucose tolerance 467 (4.6) 521 (5.0) 92 (6.7) 215 (8.6)
Antepartum hemorrhage 496 (4.9) 429 (4.1) 50 (3.6) 117 (4.7)
aAPI = Asian/Pacific Islander
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